A procedure in which a person receives stem cells, the cells from which all blood cells develop, from a compatible, though not genetically identical, donor.
The detection of genetic markers such as T(9;22)/BCR/ABL as well as the identification of resistance to therapy has direct impact on clinical management, because such high-risk features form the basis for treatment intensification, including allogeneic bone marrow transplantation (allo-BMT).